Disclosures for "Focusing on Mithocondrial Dysfunction in Multiple Sclerosis: The Role of GDF-15 and FGF-21 as Prognostic Biomarkers"
-
Dr. Carlomagno has nothing to disclose.
-
Dr. Cicia has nothing to disclose.
-
Assunta Bianco has nothing to disclose.
-
Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Matteo Lucchini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
-
Dr. Mirabella has nothing to disclose.